Cargando…

Therapeutic Potential of Targeting the HMGB1/RAGE Axis in Inflammatory Diseases

High mobility group box 1 (HMGB1) is a nuclear protein that can interact with a receptor for advanced glycation end-products (RAGE; a multi-ligand immunoglobulin receptor) and mediates the inflammatory pathways that lead to various pathological conditions, such as cancer, diabetes, neurodegenerative...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Harbinder, Agrawal, Devendra K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658169/
https://www.ncbi.nlm.nih.gov/pubmed/36364135
http://dx.doi.org/10.3390/molecules27217311